) -- Shares of

Transition Therapeutics



) were gapping up Monday morning with an open price 25.7% higher than Friday's closing price. The stock closed at $4.01 Friday and opened today's trading at $5.04.

The average volume for Transition has been 141,900 shares per day over the past 30 days. Transition has a market cap of $95.2 million and is part of the

health care

sector and


industry. Shares are up 106.7% year to date as of the close of trading on Friday.

Transition Therapeutics Inc., a biopharmaceutical company, develops novel therapeutics for various disease indications primarily in Canada.

TheStreet Ratings rates Transition as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we find that the growth in the company's earnings per share has not been good. You can view the full

Transition Ratings Report


Get more investment ideas from our

investment research center


Interested in other stocks that are gapping up? Get free SMS text alerts sent to you when the action happens by texting


to 95370 or select from

multiple alert options